Click for best price
Rheumatology Therapeutics Market Size, Share 2023
| Market size in 2022 |
US$ 47700 million
|
Forecast Market size by 2029 |
US$ 55150 million
|
| Growth Rate |
CAGR of 2.1% |
Number of Pages |
60 Pages |
The global Rheumatology Therapeutics market was valued at US$ 47700 million in 2022 and is projected to reach US$ 55150 million by 2029, at a CAGR of 2.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market.
This report aims to provide a comprehensive presentation of the global market for Rheumatology Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatology Therapeutics. This report contains market size and forecasts of Rheumatology Therapeutics in global, including the following market information:
- Global Rheumatology Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025.
We surveyed the Rheumatology Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rheumatology Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Rheumatology Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Rheumatoid Arthritis
- Osteoarthritis
- Lupus
- Gout
- Ankylosing Spondylitis
- Other
Global Rheumatology Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Rheumatology Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Retail Pharmacy
- Online Pharmacy
- Hospitals
Global Rheumatology Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Rheumatology Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rheumatology Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Rheumatology Therapeutics revenues share in global market, 2022 (%)
Key players include:
- AbbVie
- Pfizer
- Bristol-Myers Squibb Company
- Merck
- Amgen
- Janssen Biotech
- Novartis AG
- Genentech
- Takeda Pharmaceutical
- Sanofi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rheumatology Therapeutics, market overview.
Chapter 2: Global Rheumatology Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Rheumatology Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rheumatology Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Rheumatology Therapeutics Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 47700 million
|
| Forecast Market size by 2029 |
US$ 55150 million
|
| Growth Rate |
CAGR of 2.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rheumatology Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rheumatology Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rheumatology Therapeutics Overall Market Size
2.1 Global Rheumatology Therapeutics Market Size: 2022 VS 2030
2.2 Global Rheumatology Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rheumatology Therapeutics Players in Global Market
3.2 Top Global Rheumatology Therapeutics Companies Ranked by Revenue
3.3 Global Rheumatology Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Rheumatology Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Rheumatology Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatology Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Rheumatology Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Rheumatology Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rheumatology Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Rheumatoid Arthritis
4.1.3 Osteoarthritis
4.1.4 Lupus
4.1.5 Gout
4.1.6 Ankylosing Spondylitis
4.1.7 Other
4.2 By Type - Global Rheumatology Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Rheumatology Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Rheumatology Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rheumatology Therapeutics Market Size, 2022 & 2030
5.1.2 Retail Pharmacy
5.1.3 Online Pharmacy
5.1.4 Hospitals
5.2 By Application - Global Rheumatology Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Rheumatology Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Rheumatology Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Rheumatology Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Rheumatology Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Rheumatology Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Rheumatology Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Rheumatology Therapeutics Revenue, 2018-2030
6.3.2 US Rheumatology Therapeutics Market Size, 2018-2030
6.3.3 Canada Rheumatology Therapeutics Market Size, 2018-2030
6.3.4 Mexico Rheumatology Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Rheumatology Therapeutics Revenue, 2018-2030
6.4.2 Germany Rheumatology Therapeutics Market Size, 2018-2030
6.4.3 France Rheumatology Therapeutics Market Size, 2018-2030
6.4.4 U.K. Rheumatology Therapeutics Market Size, 2018-2030
6.4.5 Italy Rheumatology Therapeutics Market Size, 2018-2030
6.4.6 Russia Rheumatology Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Rheumatology Therapeutics Market Size, 2018-2030
6.4.8 Benelux Rheumatology Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Rheumatology Therapeutics Revenue, 2018-2030
6.5.2 China Rheumatology Therapeutics Market Size, 2018-2030
6.5.3 Japan Rheumatology Therapeutics Market Size, 2018-2030
6.5.4 South Korea Rheumatology Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Rheumatology Therapeutics Market Size, 2018-2030
6.5.6 India Rheumatology Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Rheumatology Therapeutics Revenue, 2018-2030
6.6.2 Brazil Rheumatology Therapeutics Market Size, 2018-2030
6.6.3 Argentina Rheumatology Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rheumatology Therapeutics Revenue, 2018-2030
6.7.2 Turkey Rheumatology Therapeutics Market Size, 2018-2030
6.7.3 Israel Rheumatology Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Rheumatology Therapeutics Market Size, 2018-2030
6.7.5 UAE Rheumatology Therapeutics Market Size, 2018-2030
7 Rheumatology Therapeutics Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Rheumatology Therapeutics Major Product Offerings
7.1.4 AbbVie Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Rheumatology Therapeutics Major Product Offerings
7.2.4 Pfizer Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Company Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Rheumatology Therapeutics Major Product Offerings
7.4.4 Merck Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Amgen
7.5.1 Amgen Company Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Rheumatology Therapeutics Major Product Offerings
7.5.4 Amgen Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Amgen Key News & Latest Developments
7.6 Janssen Biotech
7.6.1 Janssen Biotech Company Summary
7.6.2 Janssen Biotech Business Overview
7.6.3 Janssen Biotech Rheumatology Therapeutics Major Product Offerings
7.6.4 Janssen Biotech Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Janssen Biotech Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Rheumatology Therapeutics Major Product Offerings
7.7.4 Novartis AG Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Novartis AG Key News & Latest Developments
7.8 Genentech
7.8.1 Genentech Company Summary
7.8.2 Genentech Business Overview
7.8.3 Genentech Rheumatology Therapeutics Major Product Offerings
7.8.4 Genentech Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Genentech Key News & Latest Developments
7.9 Takeda Pharmaceutical
7.9.1 Takeda Pharmaceutical Company Summary
7.9.2 Takeda Pharmaceutical Business Overview
7.9.3 Takeda Pharmaceutical Rheumatology Therapeutics Major Product Offerings
7.9.4 Takeda Pharmaceutical Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Takeda Pharmaceutical Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Rheumatology Therapeutics Major Product Offerings
7.10.4 Sanofi Rheumatology Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rheumatology Therapeutics Market Opportunities & Trends in Global Market
Table 2. Rheumatology Therapeutics Market Drivers in Global Market
Table 3. Rheumatology Therapeutics Market Restraints in Global Market
Table 4. Key Players of Rheumatology Therapeutics in Global Market
Table 5. Top Rheumatology Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Rheumatology Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Rheumatology Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Rheumatology Therapeutics Product Type
Table 9. List of Global Tier 1 Rheumatology Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatology Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Rheumatology Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Rheumatology Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Rheumatology Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Rheumatology Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Rheumatology Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Rheumatology Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Rheumatology Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Rheumatology Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Rheumatology Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Rheumatology Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Rheumatology Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Rheumatology Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Rheumatology Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Rheumatology Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Rheumatology Therapeutics Product Offerings
Table 32. AbbVie Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. AbbVie Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Rheumatology Therapeutics Product Offerings
Table 36. Pfizer Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Bristol-Myers Squibb Company Company Summary
Table 39. Bristol-Myers Squibb Company Rheumatology Therapeutics Product Offerings
Table 40. Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol-Myers Squibb Company Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Rheumatology Therapeutics Product Offerings
Table 44. Merck Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Amgen Company Summary
Table 47. Amgen Rheumatology Therapeutics Product Offerings
Table 48. Amgen Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Janssen Biotech Company Summary
Table 51. Janssen Biotech Rheumatology Therapeutics Product Offerings
Table 52. Janssen Biotech Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Janssen Biotech Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG Rheumatology Therapeutics Product Offerings
Table 56. Novartis AG Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis AG Key News & Latest Developments
Table 58. Genentech Company Summary
Table 59. Genentech Rheumatology Therapeutics Product Offerings
Table 60. Genentech Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Genentech Key News & Latest Developments
Table 62. Takeda Pharmaceutical Company Summary
Table 63. Takeda Pharmaceutical Rheumatology Therapeutics Product Offerings
Table 64. Takeda Pharmaceutical Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Pharmaceutical Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Rheumatology Therapeutics Product Offerings
Table 68. Sanofi Rheumatology Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
List of Figures
Figure 1. Rheumatology Therapeutics Segment by Type in 2022
Figure 2. Rheumatology Therapeutics Segment by Application in 2022
Figure 3. Global Rheumatology Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Rheumatology Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Rheumatology Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatology Therapeutics Revenue in 2022
Figure 8. By Type - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Rheumatology Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Rheumatology Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Rheumatology Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Rheumatology Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. AbbVie Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Amgen Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Janssen Biotech Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis AG Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genentech Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Pharmaceutical Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Rheumatology Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
